These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 287665)

  • 1. The intracranial injection of drug in goldfish. I: Hallucinogens and their antagonism to smooth muscle activity.
    Abramson HA; Gettner HH; Carone PA; Rolo A; Krinsky L
    J Asthma Res; 1979 Jan; 16(2):55-61. PubMed ID: 287665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD).
    Brandt SD; Kavanagh PV; Westphal F; Stratford A; Elliott SP; Hoang K; Wallach J; Halberstadt AL
    Drug Test Anal; 2016 Sep; 8(9):891-902. PubMed ID: 26456305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
    Hungen KV; Roberts S; Hill DF
    Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD).
    Brandt SD; Kavanagh PV; Westphal F; Stratford A; Elliott SP; Dowling G; Wallach J; Halberstadt AL
    Drug Test Anal; 2019 Aug; 11(8):1122-1133. PubMed ID: 31083768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of N,N-dimethyltryptamine to evoke tolerance in cats.
    Gillin JC; Cannon E; Magyar R; Schwartz M; Wyatt RJ
    Biol Psychiatry; 1973 Dec; 7(3):213-20. PubMed ID: 4519415
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD).
    Halberstadt AL; Chatha M; Klein AK; McCorvy JD; Meyer MR; Wagmann L; Stratford A; Brandt SD
    Neuropharmacology; 2020 Aug; 172():107856. PubMed ID: 31756337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotransmitter basis of the behavioral effects of hallucinogens.
    Rech RH; Commissaris RL
    Neurosci Biobehav Rev; 1982; 6(4):521-7. PubMed ID: 6817241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of hallucinogens on blind monkeys.
    Siegel RK; Brewster JM; Johnson CA; Jarvik ME
    Int Pharmacopsychiatry; 1976; 11(3):150-6. PubMed ID: 11193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further studies on the mode of action of psychotomimetic drugs: antagonism of the excitatory actions of 5-hydroxytryptamine by methylated derivatives of tryptamine.
    Bradley PB; Briggs I
    Br J Pharmacol; 1974 Mar; 50(3):345-54. PubMed ID: 4277490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of hallucinogenic drugs on behavior of the cat.
    Jacobs BL; Trulson ME; Stark AD; Christoph GR
    Commun Psychopharmacol; 1977; 1(3):243-54. PubMed ID: 272265
    [No Abstract]   [Full Text] [Related]  

  • 11. Lysergic acid diethylamide- and mescaline-induced attenuation of the effect of punishment in the rat.
    Schoenfeld RI
    Science; 1976 May; 192(4241):801-3. PubMed ID: 1063447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance and limited cross-tolerance to the effects of N, N-dimethyltryptamine (DMT) and lysergic acid diethylamide-25 (LSD) on food-rewarded bar pressing in the rat.
    Kovacic B; Domino EF
    J Pharmacol Exp Ther; 1976 Jun; 197(3):495-502. PubMed ID: 1064726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hallucinogenic drugs are partial agonists of the human platelet shape change response: a physiological model of the 5-HT2 receptor.
    McClue SJ; Brazell C; Stahl SM
    Biol Psychiatry; 1989 Jul; 26(3):297-302. PubMed ID: 2742945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Candyflipping': synergistic discriminative effect of LSD and MDMA.
    Schechter MD
    Eur J Pharmacol; 1998 Jan; 341(2-3):131-4. PubMed ID: 9543229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An animal behavior model for studying the actions of LSD and related hallucinogens.
    Jacobs BL; Trulson ME; Stern WC
    Science; 1976 Nov; 194(4266):741-3. PubMed ID: 982043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioural effects of some derivatives of amphetamine and LSD and their significance.
    Smythies JR; Beaton J; Benington F; Morin RD
    Nature; 1970 May; 226(5246):644-5. PubMed ID: 5444927
    [No Abstract]   [Full Text] [Related]  

  • 17. Hallucinogen-induced rotational behavior in rats.
    Fleisher LN; Glick SD
    Psychopharmacology (Berl); 1979 Apr; 62(2):193-200. PubMed ID: 111284
    [No Abstract]   [Full Text] [Related]  

  • 18. Interactions of hallucinogens at the clinical level.
    Wyatt RJ; Cannon EH; Stoff DM; Gillin JC
    Ann N Y Acad Sci; 1976; 281():456-86. PubMed ID: 828469
    [No Abstract]   [Full Text] [Related]  

  • 19. The intracranial injection of drugs in goldfish. II. Preliminary report of behavior of serotonin as a potential hallucinogen when injected intracranially and intraabdominally.
    Abramson HA; Gettner HH; Rolo A
    J Asthma Res; 1980 Jul; 17(4):175-6. PubMed ID: 7263584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.
    Gresch PJ; Smith RL; Barrett RJ; Sanders-Bush E
    Neuropsychopharmacology; 2005 Sep; 30(9):1693-702. PubMed ID: 15756304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.